Literature DB >> 26342051

In Vivo Evidence of the Androgen Receptor in Association With Myometrial Cell Proliferation and Apoptosis.

Mei Lan1, Haolong Li2, Lei Bao3, Meiping Li3, Stephen Lye4, Xuesen Dong5.   

Abstract

BACKGROUND: The androgen receptor (AR) plays essential roles in female reproductive physiology. In vitro studies have shown that AR exerts 2 distinct but related functions in myometrial cells. The AR is required for myometrial cell cycling ligand independently, thereby controls myometrial cell proliferation. The AR also exerts antiapoptotic functions through myeloid cell leukemia 1 (MCL1) in both ligand-dependent and ligand-independent manners. However, these AR functions have not yet been confirmed in vivo. This study provides in vivo evidence that AR expression is associated with myometrial cell proliferation and apoptosis.
METHODS: Myometrial tissue was collected on day 6 of pregnancy from mice bearing an intact AR (AR+/+) or mice with AR heterozygous (AR-/+) or homozygous (AR-/-) functional knockout. Human uterine leiomyoma and paired myometrial tissue biopsies (n = 14 patients) were collected during hysterectomy. Immunohistochemistry was used to assess the protein expression of AR, MCL1, and Ki-67 index, as well as the functional associations of AR with MCL1 and Ki-67 index.
RESULTS: In AR-/- mice, MCL1 protein levels were reduced ∼50% in both circular and longitudinal myometrial cells when compared with that in AR+/+ and AR-/+ mice. By contrast, Ki-67 index remained unchanged. The AR protein expression and Ki-67 index in leiomyoma were ∼2- to 3-fold higher than that in normal myometrium. Although MCL1 expression was not coordinately increased in leiomyoma, strong positive correlations between AR and MCL1 expression were observed in leiomyoma but not in normal myometrium tissue.
CONCLUSION: These results suggest that AR is an important regulator of myometrial growth in vivo during pregnancy and in leiomyoma.
© The Author(s) 2015.

Entities:  

Keywords:  androgen receptor; apoptosis; myometrium; pregnancy; proliferation; uterine leiomyoma

Mesh:

Substances:

Year:  2015        PMID: 26342051     DOI: 10.1177/1933719115602771

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  4 in total

1.  Activation of β-Catenin Signaling and its Crosstalk With Estrogen and Histone Deacetylases in Human Uterine Fibroids.

Authors:  Mohamed Ali; Sara Mahmoud Shahin; Nagwa Ali Sabri; Ayman Al-Hendy; Qiwei Yang
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

2.  The Selective Progesterone Receptor Modulator Ulipristal Acetate Inhibits the Activity of the Glucocorticoid Receptor.

Authors:  Benjamin Small; Charles E F Millard; Edwina P Kisanga; Andreanna Burman; Anika Anam; Clare Flannery; Ayman Al-Hendy; Shannon Whirledge
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

3.  FKBP51 Contributes to Uterine Leiomyoma Pathogenesis by Inducing Cell Proliferation and Extracellular Matrix Deposition.

Authors:  Erika P New; Nihan Semerci; Asli Ozmen; Xiaofang Guo; Venkata A Jonnalagadda; Joung Woul Kim; Matthew L Anderson; Ozlem Guzeloglu-Kayisli; Anthony N Imudia; Charles J Lockwood; Umit A Kayisli
Journal:  Reprod Sci       Date:  2022-04-14       Impact factor: 2.924

4.  A novel mechanism of SRRM4 in promoting neuroendocrine prostate cancer development via a pluripotency gene network.

Authors:  Ahn R Lee; Yu Gan; Yuxin Tang; Xuesen Dong
Journal:  EBioMedicine       Date:  2018-08-10       Impact factor: 8.143

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.